International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10663276
Original Article
Retrospective Study of Proximal Tibia Fracture In Diabetic Adults Treated with Suprapatellar Nail
 ,
 ,
 ,
Published
Feb. 14, 2024
Abstract

This retrospective cohort study aimed to assess the clinical and radiological outcomes of utilizing a suprapatellar approach for intramedullary tibial nailing in the semi-extended knee position to manage proximal tibia fractures in patients with diabetes. Proximal tibia fractures, common in the knee joint, can significantly impact the quality of life, occurring frequently in women as they age and resulting from high-energy trauma in younger patients or low-energy fractures in the elderly. Diabetes, a known cause of delayed bone healing and soft tissue repair, can lead to diabetic dermopathy, reducing blood flow and sensation in the skin, making wound healing challenging. Additionally, high blood sugar levels in diabetes impair the immune response, increasing infection risk and further delaying healing. The study, conducted at the Department of Orthopedics in RGMC & CSMH Kalwa Thane over 18 months, included 30 patients with proximal 1/3rd Tibial fractures and mean HbA1c of 7.1, while excluding those with pathological fractures, periprosthetic fractures, deformities in the same limb, severe knee osteoarthritis, Gustilo Grade 3C open Tibial fractures, or severe soft tissue lacerations, contamination, and suprapatellar area infection. The suprapatellar approach in the semi-extended knee position offered an alternative to traditional methods, facilitating fracture reduction, especially for proximal third tibial and diaphyseal fractures, and yielding excellent functional outcomes with early radiological recovery and no postoperative anterior knee pain or malalignment. This approach appears safe, with minimal complications compared to conventional methods, making it a valuable option for managing proximal tibia fractures in diabetic patients, potentially improving fracture management and patient outcomes

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
77 Views
43 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved